Connect with:
Thursday, March 22, 2018


PREDICT Model: Estimate Benefit of Systemic Therapy Following Breast Cancer Surgery

PREDICT is a mathematical model, accessed by the internet designed for patients and doctors to help them estimate the benefit of systemic endocrine, chemo- or anti-HER2 therapy following breast cancer surgery. It is the first model of this type to include tumor HER2 and KI67 status. It can be used in place of (currently non-functional) AdjuvantOnline.

Written by

Breast Cancer Network Editorial Staff

No comments

leave a comment

- Enter Your Location -
- or -